to evaluate the risk of future epidemics. Presently,<br/>licensed antiviral drugs or vaccines against SARS-<br/>CoV, MERS-CoV, and SARS-CoV-2 are lacking.<br/>However, advances in designing antiviral drugs and<br/>vaccines against several other emerging diseases will<br/>help develop suitable therapeutic agents against<br/>COVID-19 in a short time. Until then, we must rely<br/>exclusively on various control and prevention<br/>measures to prevent this new disease from becoming<br/>a pandemic.